Skip to main content
Caplight Logo









Proseek Bio

Proseek Bio

Private
BrisbaneHealthcare & Life Scienceshttps://www.proseek.bio/

Last Round

Seed

Apr 8, 2026

Total Funding Raised

$1.06M

Company Overview

Proseek Bio is a biotechnology company that develops non-invasive, multi-biomarker blood tests for women's health, focusing on early detection of ovarian cancer using a proprietary glycoproteomics mass spectrometry platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

clinical diagnosticsovarian cancer detectionglycoproteomicsbiomarkerliquid biopsywomen's healthdiagnostic blood testpatient stratificationclinical trial enrichmentmass spectrometryprecision medicinediagnostic triagecancer screeningbiotechB2B diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proseek Bio Comparables

Compare Proseek Bio with similar companies based on industry and business-model similarity.

Proseek Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MyOncoDx, Inc.
84%
InterVenn Biosciences
84%
CpG Diagnostics, Inc.
83%

Proseek Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 8, 2026

Key People

Founding team and executive leadership

Robert Easton

Fractional CFO

Executive Team

Proseek Bio Investors

Notable investors and investment history

Proseek Bio investors
InvestorRounds
Scale InvestorsSeed
Angel LoopSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Grew 57% QoQ from 7 to 11 employees.

  • Apr 9, 2026

    Grew 67% QoQ, from 6 to 10 employees.

Recent news

Latest coverage and updates

  • hiresSep 4, 2026

    Proseek Bio Pty Limited hires David Herold as Clinical Advisor.

  • attends_eventJun 23, 2026

    Proseek Bio Pty Limited attended event 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on Jan 1st '26.

Proseek Bio Filings

Explore SEC and related filing metadata, where available.

Proseek Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Proseek Bio's valuation, stock price, and market status.

Is Proseek Bio a public or private company?

Proseek Bio is a private company.

What is the current stock price of Proseek Bio?

Proseek Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Proseek Bio worth (valuation)?

Valuation information for Proseek Bio is not publicly available.

Can I buy Proseek Bio stock?

Proseek Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Proseek Bio's last funding round?

Proseek Bio's most recent funding round was Seed on April 8, 2026.

Who are the main investors in Proseek Bio?

Key investors in Proseek Bio include Scale Investors, Angel Loop.

Will Proseek Bio IPO soon?

No public IPO plans have been announced for Proseek Bio.

How can I track Proseek Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proseek Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrisbane
Employee Range13
Year Founded2023
Last FundingApr 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?